UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 273

Sortiert nach

One‐year real‐world performance of the DBLG1 closed‐loop system: Data from 3706 adult users with type 1 diabetes in Germany

Diabetes, obesity & metabolism, 2023-06, Vol.25 (6), p.1607-1613

2023

Volltextzugriff (PDF)

Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed‐loop insulin delivery system: A series of N‐of‐1 randomized controlled trials

Diabetes, obesity & metabolism, 2021-01, Vol.23 (1), p.186-194

2021

Volltextzugriff (PDF)

Photobiomodulation promotes the functionality and viability of human pancreatic islets in basal conditions and under cytokine stress conditions

American journal of transplantation, 2024-03, Vol.24 (3), p.506-508

2024

Volltextzugriff (PDF)

Ten‐year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss‐French GRAGIL network

American journal of transplantation, 2021-11, Vol.21 (11), p.3725-3733

2021

Volltextzugriff (PDF)

The beneficial effects of closed‐loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: An extension study of the DBLHU‐WP10 trial

Diabetes, obesity & metabolism, 2022-05, Vol.24 (5), p.956-961

2022

Volltextzugriff (PDF)

Efficacy of the Diabeloop closed‐loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise

Diabetes, obesity & metabolism, 2020-03, Vol.22 (3), p.324-334

2020

Volltextzugriff (PDF)

Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab‐2 randomized controlled trial

Diabetes, obesity & metabolism, 2019-10, Vol.21 (10), p.2327-2332

2019

Volltextzugriff (PDF)

Impact of sleep and physical activity habits on real‐life glycaemic variability in patients with type 2 diabetes

Journal of sleep research, 2023-06, Vol.32 (3), p.e13799-n/a

2023

Volltextzugriff (PDF)

Prevalence of sleep apnoea in patients with type 1 diabetes and its association with comorbidities and diabetic complications: A French nationwide prospective study

Diabetes, obesity & metabolism, 2023-06, Vol.25 (6), p.1624-1631

2023

Volltextzugriff (PDF)

Assessment of plasma microvesicles to monitor pancreatic islet graft dysfunction: Beta cell‐ and leukocyte‐derived microvesicles as specific features in a pilot longitudinal study

American journal of transplantation, 2020-01, Vol.20 (1), p.40-51

2020

Volltextzugriff (PDF)

No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed‐loop system for 12 weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial

Diabetes, obesity & metabolism, 2021-09, Vol.23 (9), p.2170-2176

2021

Volltextzugriff (PDF)

Human Bone Marrow Mesenchymal Stem Cells Can Express Insulin and Key Transcription Factors of the Endocrine Pancreas Developmental Pathway upon Genetic and/or Microenvironmental Manipulation In Vitro

Stem cells (Dayton, Ohio), 2005-04, Vol.23 (4), p.594-603

2005

Volltextzugriff (PDF)

Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trial

Diabetes & metabolism, 2023-03, Vol.49 (2), p.101433-101433, Article 101433

2023

Volltextzugriff (PDF)

Islets-on-Chip: A Tool for Real-Time Assessment of Islet Function Prior to Transplantation

Transplant international, 2023-10, Vol.36, p.11512-11512

2023

Volltextzugriff (PDF)

Prospective analysis of satisfaction and usability of closed-loop Diabeloop DBLHU treatment in patients with highly unstable type 1 diabetes

Acta diabetologica, 2021-12, Vol.58 (12), p.1709-1711

2021

Volltextzugriff (PDF)

Pancreas preservation fluid microbial contamination is associated with poor islet isolation outcomes – a multi‐centre cohort study

Transplant international, 2018-08, Vol.31 (8), p.917-929

2018

Volltextzugriff (PDF)

Closed-loop insulin delivery: understanding when and how it is effective

The Lancet. Digital health, 2020-02, Vol.2 (2), p.e50-e51

2020

Volltextzugriff (PDF)

Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France

Diabetes therapy, 2021-01, Vol.12 (1), p.235-246

2021

Volltextzugriff (PDF)

Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up

Diabetes care, 2021-03, Vol.44 (3), p.844-846

2021

Volltextzugriff (PDF)

Human mesenchymal stem cells improve rat islet functionality under cytokine stress with combined upregulation of heme oxygenase-1 and ferritin

Stem cell research & therapy, 2019-03, Vol.10 (1), p.85-85, Article 85

2019

Volltextzugriff (PDF)

Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6–12 years: a randomised, controlled, cross-over, non-inferiority trial

The Lancet. Digital health, 2022-03, Vol.4 (3), p.e158-e168

2022

Volltextzugriff (PDF)

Influence of donor age on islet isolation and transplantation outcome

Transplantation, 2011-02, Vol.91 (3), p.360

2011

Volltextzugriff (PDF)

Alloimmune Monitoring after Islet Transplantation: A Prospective Multicenter Assessment of 25 Recipients

Cell transplantation, 2016-12, Vol.25 (12), p.2259-2268

2016

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

One‐year real‐world performance of the DBLG1 closed‐loop system: Data from 3706 adult users with type 1 diabetes in Germany

Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed‐loop insulin delivery system: A series of N‐of‐1 randomized controlled trials

Photobiomodulation promotes the functionality and viability of human pancreatic islets in basal conditions and under cytokine stress conditions

Ten‐year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss‐French GRAGIL network

The beneficial effects of closed‐loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: An extension study of the DBLHU‐WP10 trial

Efficacy of the Diabeloop closed‐loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise

Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab‐2 randomized controlled trial

Impact of sleep and physical activity habits on real‐life glycaemic variability in patients with type 2 diabetes

Prevalence of sleep apnoea in patients with type 1 diabetes and its association with comorbidities and diabetic complications: A French nationwide prospective study

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial

Assessment of plasma microvesicles to monitor pancreatic islet graft dysfunction: Beta cell‐ and leukocyte‐derived microvesicles as specific features in a pilot longitudinal study

No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed‐loop system for 12 weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial

Human Bone Marrow Mesenchymal Stem Cells Can Express Insulin and Key Transcription Factors of the Endocrine Pancreas Developmental Pathway upon Genetic and/or Microenvironmental Manipulation In Vitro

Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trial

Islets-on-Chip: A Tool for Real-Time Assessment of Islet Function Prior to Transplantation

Prospective analysis of satisfaction and usability of closed-loop Diabeloop DBLHU treatment in patients with highly unstable type 1 diabetes

Pancreas preservation fluid microbial contamination is associated with poor islet isolation outcomes – a multi‐centre cohort study

Liver adenomatosis in patients with hepatocyte nuclear factor‐1 alpha maturity onset diabetes of the young (HNF1A‐MODY): Clinical, radiological and pathological characteristics in a French series

Closed-loop insulin delivery: understanding when and how it is effective

Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France

Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up

Human mesenchymal stem cells improve rat islet functionality under cytokine stress with combined upregulation of heme oxygenase-1 and ferritin

Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6–12 years: a randomised, controlled, cross-over, non-inferiority trial

Influence of donor age on islet isolation and transplantation outcome

Alloimmune Monitoring after Islet Transplantation: A Prospective Multicenter Assessment of 25 Recipients

Suchergebnisse filtern